---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-017085"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:56:34.473438+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma appoints Carolyn Bonner as CFO; Jim Quinlan resigns for health reasons

## Summary
- James Quinlan resigned as CFO effective Nov 28, 2025, after medical leave since Sep 12, 2025.
- Carolyn Bonner, previously Acting CFO and President, appointed CFO effective Dec 1, 2025; will continue as President.
- Bonner's amended employment agreement: annual base salary $395,000, bonus targets escalating from 60% to 100% over five years.
- Bonner brings nearly 20 years healthcare/life sciences experience; previously CEO of PCL, Inc.

## SEC filing metadata
- accession: 0001062993-25-017085
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017085/0001062993-25-017085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017085/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-017085
- JSON: https://secwatch.observer/filing/0001062993-25-017085.json
- Plain text: https://secwatch.observer/filing/0001062993-25-017085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.